Tag: flow-mediated dilation

Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults

This randomized, double-blind, placebo-controlled crossover trial examined the impact of 6 weeks of MitoQ (20 mg/day) supplementation on vascular function in 20 healthy older adults aged 60–79 years with baseline endothelial dysfunction. MitoQ significantly enhanced brachial artery flow-mediated dilation (FMD) by 42% relative to placebo, indicating improved endothelial function. Among

Read More »

The Impact of Lipoic Acid on Endothelial Function and Proteinuria in Quinapril-Treated Diabetic Patients with Stage I Hypertension: Results from the QUALITY Study

This 2012 randomized, double-blind, crossover study investigated the effects of α-lipoic acid (ALA) on endothelial function and proteinuria in 40 diabetic patients with stage I hypertension receiving quinapril 40 mg/day. Participants were treated for 8 weeks with either quinapril alone or quinapril plus ALA 600 mg/day. Results showed that the

Read More »